MEDI ASSIST HEALTHCARE SERVICES LIMITED (MEDIASSIST) Fair Value & Analysis
Healthcare · IN · Market cap ₹28.1B (≈ $298M) · ISIN INE456Z01021
What is MEDI ASSIST HEALTHCARE SERVICES LIMITED really worth?
Below-average quality, and trading another 51% above our fair value of ₹226.12.
Strengths
Risks
Fair value as of: Aug 19, 2026
From 26 valuation models · updated 17 days ago
Share price −6.1% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits above even our optimistic bull case (₹281.58). The favourable scenario is already priced in.
- Solid but not exceptional quality (47/100) and above fair value, neither a clear bargain nor a standout compounder.
- A fairly wide model range (₹133.97 to ₹281.58) leaves room in how you read the outcome.
Price vs Fair Value (3 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 19, 2026.
How to read this chart
31‑month range ₹296.75 – ₹692.90 · fair‑value band ₹133.97 – ₹281.58 · the ₹340.35 price screens above the ₹226.12 fair value. Dashed = 300-day average. As of Aug 19, 2026.
Analysis
MEDI ASSIST HEALTHCARE SERVICES LIMITED (MEDIASSIST) currently trades at ₹340.35, while our model-based Fair Value estimate is ₹226.12, implying the stock looks roughly 50.5% overvalued today. The Quality Score stands at 47/100 (below-average quality), in the Healthcare sector. Bull case: the DCF Models group reads highest at a median of ₹368.42 per share, and 7 of the 26 models we run sit above the ₹340.35 price. Bear case: the Dividend Discount group reads lowest at ₹60.63, and 19 of the 26 models stay below the price. Evidence for this calculation is high.
Over the trailing twelve months, MEDI ASSIST HEALTHCARE SERVICES LIMITED generated revenue of ₹9.0B at a net margin of 9.7%. Revenue grew 28.1% year over year. It earns a return on equity of 12.7%. The balance sheet holds a net cash position of ₹319M. Fundamentals as of Aug 19, 2026
Our scenario range runs from ₹133.97 (bear case) to ₹281.58 (bull case); at ₹340.35, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 43% below its 52-week high and 16% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at −2% fair-value upside, at −34%, MEDIASSIST screens richer than that median.
Fair Value models
This estimate rests on fiscal year 2025 figures, and about 11 months have passed since. In that time the company retained roughly ₹11.28 per share, which is 5.0 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 26 models by family
Widest divergence: DCF Models (₹368.42) versus Dividend Discount (₹60.63). Highest evidence: FCF DCF (76).
Notify me when MEDIASSIST reaches fair value
Put MEDIASSIST on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 19, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 48 · Market factors (momentum, volatility) 30
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Medi Assist Healthcare Services Limited, together with its subsidiaries, provides third party administration services in India and internationally. The company offers business support, health management, consultancy, contact center support, and other allied services related to the healthcare and health insurance sector.
Full company description
Medi Assist Healthcare Services Limited, together with its subsidiaries, provides third party administration services in India and internationally. The company offers business support, health management, consultancy, contact center support, and other allied services related to the healthcare and health insurance sector. It also provides; and policy administration services to governments to enable public health schemes. The company was incorporated in 2000 and is headquartered in Bengaluru, India.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
MEDI ASSIST HEALTHCARE SERVICES LIMITED reported revenue of ₹9.0B in FY2025 versus ₹3.9B in FY2021, a compound +23.1%/yr. Reported net income was ₹879M in FY2025, compounding +8.2%/yr from FY2021.
MEDIASSIST screens 51% overvalued. Compare with UnitedHealth Group →
Peer Group
Healthcare Plans · 15 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Healthcare Plans median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Healthcare Plans stocks, each showing price versus our Fair Value estimate (as of Aug 19, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| UnitedHealth Group UNH | $395.05 | $292.06 | −26% |
| CVS Health Corporation CVS | $93.06 | $42.25 | −55% |
| Elevance Health, Inc ELV | $399.14 | $426.53 | +7% |
| The Cigna Group CI | $276.08 | $495.42 | +79% |
| Humana Inc HUM | $385.54 | $126.42 | −67% |
| Centene Corporation CNC | $64.75 | $111.96 | +73% |
| Molina Healthcare, Inc MOH | $203.06 | $199.31 | −2% |
| Oscar Health, Inc OSCR | $30.93 | $61.86 | +100% |
| Alignment Healthcare, Inc ALHC | $13.52 | $2.37 | −82% |
| Progyny, Inc PGNY | $25.65 | $16.44 | −36% |
Compare MEDI ASSIST HEALTHCARE SERVICES LIMITED with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is MEDI ASSIST HEALTHCARE SERVICES LIMITED (MEDIASSIST) overvalued or undervalued?
What is the fair value of MEDIASSIST?
What is the quality score of MEDIASSIST?
What is the revenue of MEDI ASSIST HEALTHCARE SERVICES LIMITED (MEDIASSIST)?
What is the net profit margin of MEDIASSIST?
Does MEDI ASSIST HEALTHCARE SERVICES LIMITED pay a dividend?
Watch MEDI ASSIST HEALTHCARE SERVICES LIMITED in the live analysis
One click puts MEDI ASSIST HEALTHCARE SERVICES LIMITED on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.